Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -36.716% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCOc1ccc(NC(=O)CN(C)C(=O)CCCn2c(=O)oc3ccccc32)cc1OCC
[b] COc1ccc(NC(=O)Nc2ccc3c(c2)N(C)C(=O)CS3)cc1Cl
Answer: a. CCOc1ccc(NC(=O)CN(C)C(=O)CCCn2c(=O)oc3ccccc32)cc1OCC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(NC(=O)CN(C)C(=O)CCCn2c(=O)oc3ccccc32)cc1OCC
CCOc1ccc(NC(=O)CN(C)C(=O)CCCn2c(=O)oc3ccccc32)cc1OCC
N-[2-(3,4-diethoxyanilino)-2-oxoethyl]-N-methyl-4-(2-oxo-1,3-benzoxazol-3-yl)butanamide